Exomes/genomes +/- mitochondrial testing various patients

Ended Purchase Order Awarded Last action

Contract number
75N92E23P00266
Awardee
Awarding agency
Obligated
$25,000

Award facts

Contract value 100% obligated
$25,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
621511 Medical Laboratories
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
MONTGOMRY VLG, MD 20877, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $25,000

About this award

Genedx, LLC, a division of Opko Health, Inc., has been awarded a $25,000 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute to provide exome and genome sequencing with optional mitochondrial testing for various patients. The contract has a period of performance of just over one year, running from September 2023 through August 2024. Genedx will perform the sequencing and testing services at its laboratory location in Montgomery Village, Maryland. This purchase order is part of the NIH's ongoing efforts to advance genomic research and its understanding of human disease through large-scale sequencing initiatives.

Quick answers

Who was awarded contract 75N92E23P00266?

75N92E23P00266 was awarded to Genedx, LLC by National Human Genome Research Institute (National Institutes of Health) on September 1, 2023.

How much is contract 75N92E23P00266 worth?

The government has obligated $25,000 on 75N92E23P00266.

Was contract 75N92E23P00266 competed?

The extent of competition for 75N92E23P00266 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award